Novel hemizygous single-nucleotide duplication in RPGR in a patient with retinal dystrophy and sensorineural hearing loss
- PMID: 38404254
- PMCID: PMC10895382
- DOI: 10.1002/mgg3.2404
Novel hemizygous single-nucleotide duplication in RPGR in a patient with retinal dystrophy and sensorineural hearing loss
Abstract
Background: The RPGR gene has been associated with X-linked cone-rod dystrophy. This report describes a variant in RPGR detected with exome sequencing (ES). Genes like RPGR have not always been included in panel-based testing and thus genome-wide tests such as ES may be required for accurate diagnosis.
Methods: The Texome Project is studying the impact of ES in medically underserved patients who are in need of genomic testing to guide diagnosis and medical management. The hypothesis is that ES could uncover diagnoses not made by standard medical care.
Results: A 58-year-old male presented with retinitis pigmentosa, sensorineural hearing loss, and a family history of retinal diseases. A previous targeted gene panel for retinal disorders had not identified a molecular cause. ES through the Texome Project identified a novel, hemizygous variant in RPGR (NM_000328.3: c.1302dup, p.L435Sfs*18) that explained the ocular phenotype.
Conclusions: Continued genetics evaluation can help to end diagnostic odysseys of patients. Careful consideration of genes represented when utilizing gene panels is crucial to ensure an accurate diagnosis. Medically underserved populations are less likely to receive comprehensive genetic testing in their diagnostic workup. Our report is an example of the medical impact of genomic medicine implementation.
Keywords: RPGR; exome sequencing; retinal dystrophy; retinitis pigmentosa.
© 2024 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Figures



References
-
- Amendola, L. M. , Hart, M. R. , Bennett, R. L. , Horike‐Pyne, M. , Dorschner, M. , Shirts, B. , & Jarvik, G. P. (2019). Insurance coverage does not predict outcomes of genetic testing: The search for meaning in payer decisions for germline cancer tests. Journal of Genetic Counseling, 28(6), 1208–1213. 10.1002/jgc4.1155 - DOI - PMC - PubMed
-
- Appelbaum, P. S. , Burke, W. , Parens, E. , Zeevi, D. A. , Arbour, L. , Nanibaa'A, G. , Bonham, V. L. , & Chung, W. K. (2022). Is there a way to reduce the inequity in variant interpretation on the basis of ancestry? American Journal of Human Genetics, 109(6), 981–988. 10.1016/j.ajhg.2022.04.012 - DOI - PMC - PubMed
-
- Branham, K. , Othman, M. , Brumm, M. , Karoukis, A. J. , Atmaca‐Sonmez, P. , Yashar, B. M. , Schwartz, S. B. , Stover, N. B. , Trzupek, K. , Wheaton, D. , Jennings, B. , Ciccarelli, M. L. , Jayasundera, K. T. , Lewis, R. A. , Birch, D. , Bennett, J. , Sieving, P. A. , Andreasson, S. , Duncan, J. L. , … Swaroop, A. (2012). Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Investigative Ophthalmology & Visual Science, 53(13), 8232–8237. 10.1167/iovs.12-11025 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources